Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion

Chiesi has agreed to acquire KalVista Pharmaceuticals for $1.9 billion, a significant move in the pharmaceutical industry. The deal aims to expand Chiesi's portfolio in innovative therapies.